Ischemic stroke therapy

Annu Rev Med. 2002:53:453-75. doi: 10.1146/annurev.med.53.082901.104106.

Abstract

Stroke is the most common life-threatening neurologic disease and the leading cause of serious long-term disability. The advent of new treatment options for selected patients suffering ischemic stroke (such as systemic administration of tissue plasminogen activator or catheter-guided intra-arterial thrombolysis), the structural reorganization of patient care facilities into stroke units, and interdisciplinary cerebrovascular centers have broadened the scope of possible therapeutic interventions in the acute and post-acute phase after cerebral ischemia. This review summarizes currently available and recommended treatment modalities for acute ischemic stroke from an interdisciplinary perspective, including medical, neurointerventional, and neurosurgical therapies.

Publication types

  • Review

MeSH terms

  • Acute Disease
  • Cerebral Infarction / diagnosis
  • Cerebral Infarction / mortality
  • Cerebral Infarction / therapy*
  • Disability Evaluation
  • Hospital Units
  • Humans
  • Prognosis
  • Survival Rate
  • Thrombolytic Therapy
  • Tissue Plasminogen Activator / administration & dosage

Substances

  • Tissue Plasminogen Activator